HUNT HAZEL (Chief Scientific Officer) exercised options at CORCEPT THERAPEUTICS INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/11/2026ACC: 0001193125-26-046881
Officer· Chief Scientific Officer
Since Jul 2020
-77.97K
Net shares
Net seller
$3.22M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
150K acquired · 227.97K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
$3.88
Trade value
$582K
% of position
81.8%
2/9/2026
183.41K→333.40K
Common Stock
Direct
Shares
−77.97K
Price / share
$41.31
Trade value
$3.22M
% of position
23.4%
2/9/2026
333.40K→255.44K
Total
Net shares
+72.03K
Net value
-$2.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | M · Option Exercise | +150K | $3.88 | $582K | 81.8% | 183.41K | 333.40K |
| Common Stock Direct | 2/9/2026 | F · Tax Withholding | −77.97K | $41.31 | $3.22M | 23.4% | 333.40K | 255.44K |
| Total | +72.03K | -$2.64M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
150K shares
Shares
−150K
Strike price
3.88
Held after
0.00
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock150K shares | 2/9/2026 | M · Option Exercise | −150K | 3.88 | — | 0.00 |